Erythropoietin receptors on cancer cells: exciting perspectives, difficult to appreciate

被引：6

作者：

Henke, Michael ^{[1
]}

Verma, Ajay ^{[1
]}

Acs, Gaza ^{[1
]}

机构：

[1] Univ Freiburg, Strahlenheilkunde Klinikum, D-79106 Freiburg, Germany

来源：

BLOOD | 2006年 / 108卷 / 03期

关键词：

D O I：

10.1182/blood-2006-03-006742

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1107 / 1108

页数：2

共 13 条

[1]

Acs G, 2001, CANCER RES, V61, P3561

[2]

Arcasoy MO, 2005, CLIN CANCER RES, V11, P20

[3] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury [J].

Brines, ML ;

Ghezzi, P ;

Keenan, S ;

Agnello, D ;

de Lanerolle, NC ;

Cerami, C ;

Itri, LM ;

Cerami, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10526-10531

[4]

Dagnon K, 2005, CLIN CANCER RES, V11, P993

[5] Anti-Epo receptor antibodies do not predict Epo receptor expression [J].

Elliott, S ;

Busse, L ;

Bass, MB ;

Lu, H ;

Sarosi, I ;

Sinclair, AM ;

Spahr, C ;

Um, M ;

Van, G ;

Begley, CG .

BLOOD, 2006, 107 (05) :1892-1895

[6] Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells [J].

Feldman, L ;

Wang, YX ;

Rhim, JS ;

Bhattacharya, N ;

Loda, M ;

Sytkowski, AJ .

PROSTATE, 2006, 66 (02) :135-145

[7] Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy:: randomised, double-blind, placebo-controlled trial [J].

Henke, M ;

Laszig, R ;

Rübe, C ;

Schäfer, U ;

Haase, KD ;

Schilcher, B ;

Mose, S ;

Beer, KGT ;

Burger, U ;

Dougherty, C ;

Frommhold, H .

LANCET, 2003, 362 (9392) :1255-1260

[8] Erythropoietin receptor is not a surrogate marker for tumor hypoxia and does not correlate with survival in head and neck squamous cell carcinomas [J].

Hoogsteen, IJ ;

Peeters, WJM ;

Marres, HAM ;

Rijken, PFJW ;

van den Hoogen, FJA ;

van der Kogel, AJ ;

Kaanders, JHAM .

RADIOTHERAPY AND ONCOLOGY, 2005, 76 (02) :213-218

[9] Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma [J].

Lai, SY ;

Childs, EE ;

Xi, SC ;

Coppelli, FM ;

Gooding, WE ;

Wells, A ;

Ferris, RL ;

Grandis, JR .

ONCOGENE, 2005, 24 (27) :4442-4449

[10] Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: A survival study [J].

Leyland-Jones, B ;

Semiglazov, V ;

Pawlicki, M ;

Pienkowski, T ;

Tjulandin, S ;

Manikhas, G ;

Makhson, A ;

Roth, A ;

Dodwell, D ;

Baselga, J ;

Biakhov, M ;

Valuckas, K ;

Voznyi, E ;

Liu, XY ;

Vercammen, E .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :5960-5972

← 1 2 →